Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.
about
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysisCost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients.
P2860
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pharmacoeconomic analysis of v ...... rile neutropenia in Australia.
@en
type
label
Pharmacoeconomic analysis of v ...... rile neutropenia in Australia.
@en
prefLabel
Pharmacoeconomic analysis of v ...... rile neutropenia in Australia.
@en
P2093
P2860
P1433
P1476
Pharmacoeconomic analysis of v ...... rile neutropenia in Australia.
@en
P2093
Daoud Al-Badriyeh
David C M Kong
Kay Stewart
P2860
P304
P356
10.1111/J.1439-0507.2011.02074.X
P50
P577
2011-07-26T00:00:00Z